We are preparing a submission to NICE regarding Rucaparib becoming available on the NHS.
The name of the NICE consultation is: Rucaparib for maintenance treatment of recurrent platinum-sensitive epithelial ovarian, fallopian tube and peritoneal cancer that has responded to platinum-based chemotherapy.
It would be really helpful if any of you who are taking Rucaparib or who took part in the ARIEL 3 trial have comments you'd be willing for us to share within our submission - we wouldn't use your name or any identifying details.
Do get in touch if you have any questions.
Many thanks for your help, as always.
Ovacome Support Service Manager